24.07.2012 • Newsbio-basedbio-succinic acidBioAmber

NatureWorks and BioAmber create AmberWorks

NatureWorks, a bio-plastics manufacturer, and BioAmber, a producer of bio-succinic acid, have created AmberWorks, a joint venture to bring a new family of bio-based compounded polymer solutions to market. With the formation of the joint venture, NatureWorks plans to commercialize a new family of compounded PLA/PBS resin grades, and is immediately offering samples of developmental grades aimed at thermoforming and injection-molding processes. This new family of developmental compounded resins is designed for food service ware applications. Based on market interest, further formulated solutions optimized for a number of different applications beyond food service will be assessed over the coming 12 to 24 months.

While an assessment of the European Union chemical regulation REACH status is underway, research and development samples are available in Europe at NatureWorks Europe (mailto:email:nw_europe@natureworksllc.com), Naarden, The Netherlands. The regulatory status of these grades in other geographies is under review.

BioAmber owns PLA/PBS compounding intellectual property and applies biotechnology and chemical processing to produce renewable chemicals. These renewable chemicals deliver high-performance, low-carbon-footprint building blocks that are cost competitive with their petrochemical equivalents. Beyond its Ingeo PLA technology platform, NatureWorks brings to the joint venture a global commercial presence, established customer relationships, developed applications across a breadth of industries and deep experience in commercializing new polymers.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.